首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2050457

血液製品市場：依產品類型、應用、技術、患者群、最終用戶和地區分類

Blood Products Market, By Product Category, By Application, By Technology, By Patient Demographics, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，血液製品市場規模將達到401億美元，到2033年將達到560.1億美元。預計從2026年到2033年，其複合年成長率將達到4.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	401億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.90%	2033年市場規模預測：	5610億美元

近年來，受慢性病患病率上升、輸血需求增加以及血液處理和儲存技術進步的推動，全球血液製品市場經歷了顯著成長。包括全血、紅血球、血小板、血漿及其他衍生品在內的血液製品在眾多醫療程序和治療中發揮著至關重要的作用。該市場涵蓋了包括白蛋白、免疫球蛋白、凝血因子及其他血漿衍生產品在內的多種產品。隨著全球醫療保健產業的不斷發展和對救命血液製品需求的持續成長，預計未來幾年血液製品市場將迎來顯著成長。

市場動態：

全球血液製品市場受多種關鍵因素影響，這些因素既推動其成長，也限制其擴張，並為相關人員帶來機會。其中一個主要市場促進因素是癌症、心血管疾病和血液系統疾病等慢性病的日益普遍，這些疾病通常需要輸血和其他血液相關治療。此外，全球人口老化加劇以及外科手術數量的增加也推動了對血液製品的需求。然而，該市場也面臨許多限制因素，例如血液採集、處理和儲存高成本，以及輸血感染的風險。此外，嚴格的監管要求和血液製品保存期限短也對市場成長構成挑戰。儘管有這些限制因素，血液製品市場仍蘊藏著巨大的成長機遇，包括先進血液處理技術的開發、血庫自動化程度的提高以及血漿療法的推廣應用。此外，新興經濟體醫療基礎設施的改善和醫療支出的成長推動了血液製品需求的不斷成長，這也為市場相關人員提供了巨大的成長前景。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球血液製品市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品等級改進、市場擴張和行銷策略做出明智的決策。
這份全球血液製品市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球血液製品市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Grifols
CSL Behring
Fresenius Kabi
Octapharma
Takeda Pharmaceutical Company
Sanofi
Kedrion Biopharma
Biotest AG
Mitsubishi Tanabe Pharma Corporation
HemaCare
BloodCenter of Wisconsin
Terumo BCT
Prothera Biosciences
American Red Cross
Vitalant

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8054

Blood Products Market is estimated to be valued at USD 40.10 Bn in 2026 and is expected to reach USD 56.01 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 40.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.90%	2033 Value Projection:	USD 56.01 Bn

The global blood products market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for blood transfusions, and advancements in blood processing and storage technologies. Blood products, including whole blood, red blood cells, platelets, plasma, and other derivatives, play a crucial role in various medical procedures and treatments. The market encompasses a wide range of products such as albumin, immunoglobulins, coagulation factors, and other plasma-derived products. As the global healthcare industry continues to evolve and the demand for life-saving blood products rises, the blood products market is poised for substantial growth in the coming years.

Market Dynamics:

The global blood products market is influenced by several key factors that drive its growth, restrain its expansion, and present opportunities for stakeholders. One of the primary drivers of the market is the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and hematological conditions, which often require blood transfusions and other blood-related treatments. Additionally, the growing geriatric population worldwide, coupled with the rising incidence of surgical procedures, contributes to the heightened demand for blood products. However, the market also faces certain restraints, including the high costs associated with blood collection, processing, and storage, as well as the risk of transfusion-transmitted infections. Moreover, stringent regulatory requirements and the limited shelf life of blood products pose challenges to market growth. Despite these restraints, the blood products market presents significant opportunities for growth, such as the development of advanced blood processing technologies, the increasing adoption of automation in blood banks, and the expansion of plasma-derived therapies. Furthermore, the rising demand for blood products in emerging economies, driven by improving healthcare infrastructure and increasing healthcare expenditure, offers substantial growth prospects for market players.

Key Features of the Study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Grifols, CSL Behring, Fresenius Kabi, Octapharma, Takeda Pharmaceutical Company, Sanofi, Kedrion Biopharma, Biotest AG, Mitsubishi Tanabe Pharma Corporation, HemaCare, BloodCenter of Wisconsin, Terumo BCT, Prothera Biosciences, American Red Cross, and Vitalant
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood products market

Market Segmentation

Product Category Insights (Revenue, USD Bn, 2021 - 2033)
Whole Blood
Blood Components
- Red Blood Cells (RBCs)
- Platelets
- Plasma
- White Blood Cells (WBCs)
- Cryoprecipitate
Plasma-derived Products
- Immunoglobulins
- Albumin
- Coagulation Factors
- Hyperimmune Globulins
- Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Hematology
Immunology
Neurology
Oncology
Hematology
Others
Technology Insights (Revenue, USD Bn, 2021 - 2033)
Manual Blood Collection and Processing
Automated Blood Collection Systems
Blood Fractionation and Plasma Separation
Pathogen Reduction Technologies
Precision Blood Typing and Grouping Systems
Others
Patient Demographics Insights (Revenue, USD Bn, 2021 - 2033)
Pediatric Patients
Adult Patients
Geriatric Patients
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Blood Banks
Ambulatory Surgical Centers
Transfusion Centers
Diagnostic Laboratories
Research Institutions

Regional Insights (Revenue, USD Bn, 2021 - 2033)

North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Grifols
CSL Behring
Fresenius Kabi
Octapharma
Takeda Pharmaceutical Company
Sanofi
Kedrion Biopharma
Biotest AG
Mitsubishi Tanabe Pharma Corporation
HemaCare
BloodCenter of Wisconsin
Terumo BCT
Prothera Biosciences
American Red Cross
Vitalant

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Products Market, By Product Category
- Global Blood Products Market, By Application
- Global Blood Products Market, By Technology
- Global Blood Products Market, By Patient Demographics
- Global Blood Products Market, By End User
- Global Blood Products Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Products Market, By Product Category, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Blood Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Red Blood Cells (RBCs)
  - Platelets
  - Plasma
  - White Blood Cells (WBCs)
  - Cryoprecipitate
Plasma-derived Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Immunoglobulins
  - Albumin
  - Coagulation Factors
  - Hyperimmune Globulins
  - Others

5. Global Blood Products Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Blood Products Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Manual Blood Collection and Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Automated Blood Collection Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Blood Fractionation and Plasma Separation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pathogen Reduction Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Precision Blood Typing and Grouping Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Blood Products Market, By Patient Demographics, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Blood Products Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Transfusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Blood Products Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kedrion Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotest AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HemaCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BloodCenter of Wisconsin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo BCT
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Prothera Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
American Red Cross
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vitalant
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies